Cardiac performance and left ventricular dimensions in neonates with left-sided congenital diaphragmatic hernia before and after surgical repair Authors: Mohamed Mahmoud Shalaby, Fatma Aboalsoud Taha Published: 2026 ABSTRACT BackgroundCongenital Diaphragmatic Hernia (CDH) is associated with significant cardiopulmonary morbidity. Pulmonary Hypertension (PH) and left ventricular (LV) dysfunction are major determinants of outcome. While the impact of CDH repair on pulmonary hemodynamics is recognized, comprehensive serial assessment of cardiac performance, specifically LV dimensions and function, surrounding surgical repair is limited.ObjectivesTo characterize changes in LV dimensions, systolic/diastolic function, and global cardiac performance in neonates with CDH immediately before and within 48–72 h after surgical repair.MethodsA prospective observational cohort study conducted between January 2022 and January 2025 in our tertiary center. Term neonates with isolated, left-sided Bochdalek CDH requiring surgical repair were included. Comprehensive transthoracic echocardiography (TTE) was performed at three time points: (1) Pre-Operative (Pre-Op): Within 24 h before repair (after initial stabilization), (2) Early Post-Operative (E-Post-Op): 48–72 h after completion of surgical repair. (3) One-month Post-Operative (M-Post-Op): One month after completion of surgical repair. Parameters measured from the LV and from the right ventricle (RV), Ventilator settings, inotrope score, and vasoactive-inotrope score (VIS) were recorded concurrently. Data were recorded and analyzed.ResultsThirty neonates met the inclusion criteria (Median gestational age: 38 weeks [IQR 37–39], Birth weight: 3.0kg [IQR 2.7–3.3]). Significant PH was present pre-operatively in 70% (n = 21). Parameters of LV dimensions and function revealed: Left ventricular end-diastolic dimension (LVEDD) and left ventricular end-systolic dimension (LVESD) (absolute and z-score) increased significantly early and one-month post-repair (p < 0.05*). Left ventricular fractional shortening (LVFS), left ventricular ejection fraction (LVEF), and left ventricular global longitudinal strain (LVGLS) decreased significantly in the early post-operative period, then increased again to their normal levels one-month post-repair (p < 0.05*). The decrease in LV systolic function correlated with higher peak Post-Op VIS (r = -0.45, p = 0.01). Improvement in LVEDD correlated with lower oxygen requirements at 7 days post-op (r = -0.38, p = 0.03). The mitral inflow E/A ratio decreased significantly early post-repair and then improved for one month (p = 0.004*), while the average E/e’ ratio did not change significantly. Parameters reflecting RV systolic function improved immediately post-repair: Tricuspid annular plane systolic excursion (TAPSE) and Right Ventricular global longitudinal strain (RVGLS) increased significantly (p < 0.05*). Estimated systolic pulmonary artery pressure (ESPAP) decreased significantly (p = 0.002*) and ventricular septal flattening was significantly less common post-repair.ConclusionsSurgical repair of CDH induces significant acute changes in cardiac performance. While reduction of herniated viscera rapidly improves LV dimensions (indicating relief of compression) and RV function/PAP, it is also associated with a transient impairment in LV systolic function and altered diastolic relaxation pattern in the immediate post-operative period. Introduction Congenital Diaphragmatic Hernia (CDH) remains a significant cause of neonatal morbidity and mortality, primarily due to pulmonary hypoplasia and persistent pulmonary hypertension (PH) [1, 2]. The pathophysiology involves complex cardiopulmonary interactions. The herniated abdominal contents compress the developing lung and cause mediastinal shift, leading to underdevelopment of both the pulmonary vasculature and the cardiac chambers, particularly the left ventricle (LV) [3, 4]. This LV hypoplasia and dysfunction, compounded by elevated right ventricular (RV) afterload from PH, significantly impact global cardiac output and oxygen delivery [5, 6]. Surgical repair of the diaphragmatic defect is essential but represents a major physiological stressor. Reduction of herniated viscera alters intrathoracic pressures, reduces mediastinal shift, and can acutely change preload and afterload conditions for both ventricles [7]. While studies have documented improvements in pulmonary hemodynamics (e.g., reduced PH) following repair [8, 9], detailed serial characterization of LV dimensions and performance immediately before and after surgery is less comprehensive. Understanding the acute perioperative changes in LV size and function is crucial. Pre-operative LV hypoplasia and dysfunction are known predictors of mortality [4, 10]. So, Cardiac dysfunction may play an equal or greater role than pulmonary hypertension in CDH outcomes. However, the immediate impact of surgical decompression on LV filling, systolic performance, and diastolic properties remains incompletely defined. Does LV size normalize rapidly? Is there a predictable pattern of systolic or diastolic dysfunction post-repair? How do these changes correlate with clinical status and support requirements? This prospective cohort study aimed to address these gaps by performing comprehensive transthoracic echocardiography (TTE) in neonates with isolated left-sided CDH immediately before and within 48–72 h after surgical repair. Methods Study design and population A prospective observational cohort study was approved by the Institutional Review Board (IRB) at our tertiary center (Protocol 36264PR908/10/24) and complied with the 1964 Helsinki ethical declaration and its later amendments. Written informed consent was obtained from parents/guardians before enrollment. Thirty term neonates (≥ 37 weeks’ gestation) with a prenatal or postnatal diagnosis of isolated, left-sided Bochdalek CDH admitted to the neonatal intensive care unit (NICU) between January 2022 and January 2025 and scheduled for surgical repair were eligible. Exclusion criteria included major associated congenital heart defects (excluding atrial septal defect (ASD), ventricular septal defect (VSD), or patent ductus arteriosus (PDA)), right-sided CDH, syndromic diagnoses, need for extracorporeal membrane oxygenation (ECMO) cannulation before repair, or parental refusal. Right-sided CDH was excluded to maintain a homogeneous cohort, as right CDH differs significantly in cardiac compression patterns and hemodynamics. Management protocol All neonates received standardized management per institutional CDH protocol, including gentle ventilation strategies, hemodynamic monitoring, treatment of PH (inhaled nitric oxide (iNO), sildenafil, milrinone as indicated), and nutritional support. PH was defined as estimated PAP ≥ 2/3 systemic pressure. Decisions regarding iNO were based on institutional protocol. Surgical repair (open or minimally invasive) was performed once deemed clinically stable (mean airway pressure ≤ 15 cmH2O, FiO2 ≤ 0.5, lactate < 3 mmol/L, minimal inotropic support, stable PH). All procedures were performed under standardized general anesthesia with invasive arterial monitoring. Intraoperative hemodynamic stability was maintained using protocolized fluid and vasoactive support. Post-operative care followed standard NICU protocols. Echocardiography protocol Comprehensive TTE was performed by experienced pediatric cardiac sonographers using a GE Vivid E95 system, following American Society of Echocardiography (ASE) guidelines for neonatal quantification [11]. Studies were performed at three defined timepoints: Pre-Operative (Pre-Op): Within 24 h before surgical repair, after initial stabilization and optimization for surgery.Early Post-Operative (E-Post-Op): 48–72 h after completion of surgical repair.Month Post-Operative (M-Post-OP): One month after completion of surgical repair. Pre-Operative (Pre-Op): Within 24 h before surgical repair, after initial stabilization and optimization for surgery. Pre-Operative (Pre-Op): Within 24 h before surgical repair, after initial stabilization and optimization for surgery. Early Post-Operative (E-Post-Op): 48–72 h after completion of surgical repair. Early Post-Operative (E-Post-Op): 48–72 h after completion of surgical repair. Month Post-Operative (M-Post-OP): One month after completion of surgical repair. Month Post-Operative (M-Post-OP): One month after completion of surgical repair. All studies were stored digitally and analyzed offline. The measured parameters included: LV Dimensions & Systolic Function: LV end-diastolic dimension (LVEDD), LV end-systolic dimension (LVESD) (parasternal long-axis), their Z-scores [12], LV fractional shortening (LVFS) (LVFS = [(LVEDD-LVESD)/LVEDD]x100), LV ejection fraction (LVEF) (using Simpson’s biplane method from apical 4- and 2-chamber views) and left ventricular global longitudinal strain (LVGLS).LV Diastolic Function: Mitral inflow pulsed-wave Doppler (E-wave, A-wave, E/A ratio), tissue doppler imaging (TDI) of the mitral annulus (septal and lateral e’ waves, average E/e’ ratio).RV Function & Pulmonary Hemodynamics: Tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (RVFAC), RVFAC was measured from the apical four-chamber view, Right Ventricular global longitudinal strain (RVGLS), estimated systolic pulmonary artery pressure (ESPAP). Qualitative assessment of ventricular septal position (normal, flattened, bowed). LV Dimensions & Systolic Function: LV end-diastolic dimension (LVEDD), LV end-systolic dimension (LVESD) (parasternal long-axis), their Z-scores [12], LV fractional shortening (LVFS) (LVFS = [(LVEDD-LVESD)/LVEDD]x100), LV ejection fraction (LVEF) (using Simpson’s biplane method from apical 4- and 2-chamber views) and left ventricular global longitudinal strain (LVGLS). LV Dimensions & Systolic Function: LV end-diastolic dimension (LVEDD), LV end-systolic dimension (LVESD) (parasternal long-axis), their Z-scores [12], LV fractional shortening (LVFS) (LVFS = [(LVEDD-LVESD)/LVEDD]x100), LV ejection fraction (LVEF) (using Simpson’s biplane method from apical 4- and 2-chamber views) and left ventricular global longitudinal strain (LVGLS). LV Diastolic Function: Mitral inflow pulsed-wave Doppler (E-wave, A-wave, E/A ratio), tissue doppler imaging (TDI) of the mitral annulus (septal and lateral e’ waves, average E/e’ ratio). LV Diastolic Function: Mitral inflow pulsed-wave Doppler (E-wave, A-wave, E/A ratio), tissue doppler imaging (TDI) of the mitral annulus (septal and lateral e’ waves, average E/e’ ratio). RV Function & Pulmonary Hemodynamics: Tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (RVFAC), RVFAC was measured from the apical four-chamber view, Right Ventricular global longitudinal strain (RVGLS), estimated systolic pulmonary artery pressure (ESPAP). Qualitative assessment of ventricular septal position (normal, flattened, bowed). RV Function & Pulmonary Hemodynamics: Tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (RVFAC), RVFAC was measured from the apical four-chamber view, Right Ventricular global longitudinal strain (RVGLS), estimated systolic pulmonary artery pressure (ESPAP). Qualitative assessment of ventricular septal position (normal, flattened, bowed). To ensure reproducibility, a subset of studies (20%) was re-analyzed by the same observer and a second independent observer. Intra- and interobserver variability for LVGLS and RVGLS were assessed using intraclass correlation coefficients (ICC). Strain analysis was performed offline using GE EchoPAC software (version 203 or 204, GE Healthcare, Horten, Norway), with frame rates optimized between 60 and 90 frames per second, in accordance with current recommendations for speckle-tracking echocardiography in neonates. Clinical data collection Demographic data (gestational age, birth weight, sex), prenatal diagnosis, defect size (Diaphragmatic hernia defect sizes are often classified by surgeons using a four-tier system (A, B, C, D) based on the percentage of diaphragm tissue present, with ‘A’ defect is surrounded entirely by muscle with > 90% hemidiaphragm present, a ‘B’ defect has 50%–75% present, a ‘C’ defect < 50% and a ‘D’ defect is a complete or near complete absent hemidiaphragm (< 10%). This classification is important for risk stratification, with Type C and D defects considered high-risk due to a greater impact on lung development and a higher mortality rate [7, 13]. Age at repair, type of repair (open vs. thoracoscopic), duration of surgery, and use of patch were recorded. Concurrent clinical data at each TTE timepoint included: mechanical ventilator settings (mean airway pressure (MAP), FiO2, arterial blood gas parameters (pH, lactate), heart rate, blood pressure, and vasoactive medication use (dopamine, dobutamine, epinephrine, norepinephrine, milrinone, vasopressin). Inotrope score [14] and Vasoactive-Inotrope Score (VIS) [15] were calculated. In the pre-operative period, the VIS was primarily driven by low-dose dopamine (median 5 mcg/kg/min) and milrinone (median 0.25 mcg/kg/min). In the early post-operative period where VIS peaked, the increase was primarily due to the addition of or uptitration of epinephrine (median 0.05 mcg/kg/min) in 11 patients (37%) to support blood pressure in the setting of the observed transient LV dysfunction. Oxygenation index (OI = [MAP x FiO2 × 100] / PaO2) and Oxygen saturation index (OSI = [MAP x FiO2 × 100] / SpO2) were calculated where arterial blood gas was available. Outcomes recorded included: need for ECMO post-repair, duration of mechanical ventilation, length of NICU stay, and survival to discharge. Statistical analysis Data were analyzed using SPSS Statistics version 28.0 (IBM Corp.). Normality was assessed using Shapiro-Wilk tests. Continuous variables are presented as mean ± standard deviation (SD) if normally distributed. Categorical variables are presented as numbers and percentages. Comparisons between Pre-Op and Post-Op measurements for continuous variables were made using paired t-tests for normally distributed data. Categorical variables were compared using Chi-square or Fisher’s exact test as appropriate. For repeated measures ANOVA test was used. Correlations between changes in echocardiographic parameters and clinical variables were assessed using Pearson’s or Spearman’s correlation coefficients as appropriate. A p-value < 0.05 was considered statistically significant. Post-hoc analysis was not performed and represents a limitation. A formal calculation was not feasible due to the exploratory physiologic nature of the study and the limited number of eligible CDH cases. Therefore, the sample size reflects all consecutive patients meeting inclusion criteria during the study period. Results Patient characteristics Thirty neonates met the inclusion criteria. Baseline characteristics are summarized in Table 1. Prenatal diagnosis was made in 87% (n = 26). The median age at repair was 4 days (IQR 3–6 days). Most repairs were performed via laparotomy (83%, n = 25), and a patch was required in 60% (n = 18). Significant pre-operative PH (Pulmonary artery pressure (PAP) ≥ 2/3 systemic by echocardiography) was present in 70% (n = 21). All patients survived to the post-operative echocardiogram. The mean timing of the early post-operative echocardiography was 60 ± 12 h post-repair. Three infants required ECMO post-repair (all cannulated > 72 h post-op and thus included in the Post-Op TTE analysis). Table 1Patient Demographics and Baseline Characteristics (N = 30)CharacteristicValue Gestational Age (weeks) 38.1 ± 0.9 Birth Weight (kg) 3.0 ± 0.4 Male Sex 20 (66.7%) Prenatal Diagnosis 26 (86.7%) Liver Up 19 (63.3%) Defect Size • A > 90% hemidiaphragm present• B defect has 50%–75% present• C defect < 50%• D defect is a complete or near complete3 (10%)10 (33%)12 (40%)5 (17%) Age at Repair (days) 4.0 ± 1.5 Open Repair 25 (83.3%) Patch Repair 18 (60.0%) Pre-Op PH (PAP ≥ 2/3 systemic) 21 (70.0%) Pre-Op iNO Use 17 (56.7%) Pre-Op VIS 8.2 ± 3.7iNO: Inhaled nitric oxide, PAP: Pulmonary artery pressure, PH: Pulmonary hypertension, Pre-Op: Pre-Operative, VIS: Vasoactive-inotrope score Table 1Patient Demographics and Baseline Characteristics (N = 30)CharacteristicValue Gestational Age (weeks) 38.1 ± 0.9 Birth Weight (kg) 3.0 ± 0.4 Male Sex 20 (66.7%) Prenatal Diagnosis 26 (86.7%) Liver Up 19 (63.3%) Defect Size • A > 90% hemidiaphragm present• B defect has 50%–75% present• C defect < 50%• D defect is a complete or near complete3 (10%)10 (33%)12 (40%)5 (17%) Age at Repair (days) 4.0 ± 1.5 Open Repair 25 (83.3%) Patch Repair 18 (60.0%) Pre-Op PH (PAP ≥ 2/3 systemic) 21 (70.0%) Pre-Op iNO Use 17 (56.7%) Pre-Op VIS 8.2 ± 3.7iNO: Inhaled nitric oxide, PAP: Pulmonary artery pressure, PH: Pulmonary hypertension, Pre-Op: Pre-Operative, VIS: Vasoactive-inotrope score Patient Demographics and Baseline Characteristics (N = 30) Defect Size • A > 90% hemidiaphragm present • B defect has 50%–75% present • C defect < 50% • D defect is a complete or near complete 3 (10%) 10 (33%) 12 (40%) 5 (17%) iNO: Inhaled nitric oxide, PAP: Pulmonary artery pressure, PH: Pulmonary hypertension, Pre-Op: Pre-Operative, VIS: Vasoactive-inotrope score Echocardiographic findings Key echocardiographic parameters before and after repair are presented in Table 2; Figs. 1 and 2. LV dimensions LVEDD and LVESD (absolute and z-score) increased significantly early post-repair and one-month post-repair (p < 0.05*), indicating an increase in LV size. LV systolic function LVFS, LVEF, and LVGLS decreased significantly in the early post-operative period, then increased again to their normal levels one-month post-repair (p < 0.05*). LV diastolic function The mitral inflow E/A ratio decreased significantly early post-repair and then improved for one month (p = 0.004*), suggesting altered LV relaxation or increased atrial contribution early post-operative. The average E/e’ ratio did not change significantly. RV function & PH: Parameters reflecting RV systolic function improved immediately post-repair: TAPSE and RVGLS increased significantly (p < 0.05*). RVFAC showed a positive trend but did not reach statistical significance. ESPAP decreased significantly (p = 0.002*), indicating a reduction in pulmonary artery pressure. Ventricular septal flattening was significantly less common post-repair. TR jet was not measurable in all patients, and alternative echocardiographic markers were used to assess PH. In its absence, PH was assessed using septal position and ductal flow patterns. Table 2Echocardiographic Parameters Before and After CDH RepairParameterPre-OperativeEarly post-operativeMonth post-operativep-value Left Ventricle (LV) - Size LVEDD (cm) 1.58 ± 0.211.82 ± 0.231.94 ± 0.32< 0.001* LVEDD z-score -1.8 ± 0.9-0.7 ± 0.8-0.6 ± 0.4< 0.001* LVESD (cm) 1.01 ± 0.161.30 ± 0.181.32 ± 0.130.01* LVESD z-score -1.6 ± 0.5-0.7 ± 0.8-0.7 ± 0.20.03* Left Ventricle (LV) - Function LVFS (%) 28 ± 623 ± 730 ± 40.003* LVEF (%) 58 ± 852 ± 961 ± 60.008* LVGLS (%) − 17.2 ± 5.8− 15.4 ± 3.5− 21.2 ± 4.7< 0.001* Diastolic Function Mitral E/A Ratio 0.85 ± 0.150.72 ± 0.120.93 ± 0.170.004* TDI E/e’ Ratio 12.1 ± 3.213.1 ± 2.911.5 ± 4.10.06 Right Ventricle (RV) - Function TAPSE (mm) 16.2 ± 1.518.8 ± 1.719.2 ± 0.90.004* RVFAC (%) 33 ± 835 ± 735 ± 60.07 RVGLS − 13.2 ± 5.8− 20.8 ± 3.5− 21.2 ± 4.7< 0.001* Pulmonary Artery Pressure ESPAP 39 ± 624 ± 523 ± 70.002* Septal Flattening Ventricular Septal Position (Flat/Bowing) Present in 24/30 (80%)Present in 8/30 (27%)Present in 2/30 (7%)< 0.001*ESPAP: Estimated systolic pulmonary artery pressure, LVEDD: Left ventricular end-diastolic dimension, LVEF: Left ventricular ejection fraction, LVESD: Left ventricular end-systolic dimension, LVFS: Left ventricular fractional shortening, LVGLS: Left ventricular global longitudinal strain, RVFAC: Right ventricular fractional area change, RVGLS: Right Ventricular global longitudinal strain, TAPSE: Tricuspid annular plane systolic excursion, TDI: Tissue doppler imaging*Note: A p-value < 0.05 is generally considered statistically significant. * Table 2Echocardiographic Parameters Before and After CDH RepairParameterPre-OperativeEarly post-operativeMonth post-operativep-value Left Ventricle (LV) - Size LVEDD (cm) 1.58 ± 0.211.82 ± 0.231.94 ± 0.32< 0.001* LVEDD z-score -1.8 ± 0.9-0.7 ± 0.8-0.6 ± 0.4< 0.001* LVESD (cm) 1.01 ± 0.161.30 ± 0.181.32 ± 0.130.01* LVESD z-score -1.6 ± 0.5-0.7 ± 0.8-0.7 ± 0.20.03* Left Ventricle (LV) - Function LVFS (%) 28 ± 623 ± 730 ± 40.003* LVEF (%) 58 ± 852 ± 961 ± 60.008* LVGLS (%) − 17.2 ± 5.8− 15.4 ± 3.5− 21.2 ± 4.7< 0.001* Diastolic Function Mitral E/A Ratio 0.85 ± 0.150.72 ± 0.120.93 ± 0.170.004* TDI E/e’ Ratio 12.1 ± 3.213.1 ± 2.911.5 ± 4.10.06 Right Ventricle (RV) - Function TAPSE (mm) 16.2 ± 1.518.8 ± 1.719.2 ± 0.90.004* RVFAC (%) 33 ± 835 ± 735 ± 60.07 RVGLS − 13.2 ± 5.8− 20.8 ± 3.5− 21.2 ± 4.7< 0.001* Pulmonary Artery Pressure ESPAP 39 ± 624 ± 523 ± 70.002* Septal Flattening Ventricular Septal Position (Flat/Bowing) Present in 24/30 (80%)Present in 8/30 (27%)Present in 2/30 (7%)< 0.001*ESPAP: Estimated systolic pulmonary artery pressure, LVEDD: Left ventricular end-diastolic dimension, LVEF: Left ventricular ejection fraction, LVESD: Left ventricular end-systolic dimension, LVFS: Left ventricular fractional shortening, LVGLS: Left ventricular global longitudinal strain, RVFAC: Right ventricular fractional area change, RVGLS: Right Ventricular global longitudinal strain, TAPSE: Tricuspid annular plane systolic excursion, TDI: Tissue doppler imaging*Note: A p-value < 0.05 is generally considered statistically significant. * Echocardiographic Parameters Before and After CDH Repair ESPAP: Estimated systolic pulmonary artery pressure, LVEDD: Left ventricular end-diastolic dimension, LVEF: Left ventricular ejection fraction, LVESD: Left ventricular end-systolic dimension, LVFS: Left ventricular fractional shortening, LVGLS: Left ventricular global longitudinal strain, RVFAC: Right ventricular fractional area change, RVGLS: Right Ventricular global longitudinal strain, TAPSE: Tricuspid annular plane systolic excursion, TDI: Tissue doppler imaging *Note: A p-value < 0.05 is generally considered statistically significant. * Fig. 1(A) Pulmonary hypertension with RV dilatation and impairment of RV function. (B) 3 months post repair, the patient showed improvement of Pulmonary artery pressure, reduction of RV dimensions, and improvement of RV function (A) Pulmonary hypertension with RV dilatation and impairment of RV function. (B) 3 months post repair, the patient showed improvement of Pulmonary artery pressure, reduction of RV dimensions, and improvement of RV function Fig. 2Boxplots of Left Ventricular Echocardiographic Changes (LVEDD z-score, LVEF, LVGLS, mitral E/A ratio Boxplots of Left Ventricular Echocardiographic Changes (LVEDD z-score, LVEF, LVGLS, mitral E/A ratio Clinical correlates The decrease in LVEF E-Post-Op correlated significantly with the peak VIS recorded E-Post-Op (r = -0.45, p = 0.01). A greater drop in LVEF was associated with higher vasoactive support needs. The increase in LVEDD z-score E-Post-Op correlated inversely with the FiO2 requirement at 7 days Post-Op (r = -0.38, p = 0.03). Greater LV dilation post-repair was associated with lower oxygen needs a week later. Figure 3. Fig. 3Boxplots of Right Ventricular Echocardiographic Changes (TAPSE, RVGLS, ESPAP) Boxplots of Right Ventricular Echocardiographic Changes (TAPSE, RVGLS, ESPAP) No significant correlations were found between changes in LVFS or E/A ratio and clinical parameters like VIS or OI/OSI at the E-Post-Op TTE timepoint. Infants requiring patch repair had significantly lower Pre-Op LVEDD z-scores (-2.1 ± 0.8 vs. -1.3 ± 0.8 for primary repair, p = 0.02*) and a trend towards lower E-Post-Op LVEF (50% ± 9% vs. 55% ± 8%, p = 0.08*). Clinical outcomes Median duration of mechanical ventilation was 18 days (IQR 12–28 days). Median length of NICU stay was 42 days (IQR 32–58 days). Three infants (10%) required ECMO post-repair (all > 72 h post-op). All 30 infants survived to discharge. Discussion This prospective study provides detailed serial characterization of cardiac performance, with a specific focus on LV dimensions and function, in neonates undergoing CDH repair. The key findings are: (1) A significant increase in LV dimensions (LVEDD, LVESD) immediately post-repair and along follow-up; (2) A transient but significant decrease in LV systolic function (LVFS, LVEF); (3) A transient altered LV diastolic relaxation pattern (decreased E/A ratio); (4) Concurrent improvement in RV systolic function (TAPSE) and pulmonary hemodynamics (ESPAP); and (5) Correlations linking worse E-Post-Op LV systolic function to higher vasoactive support needs and greater LV dilation to better subsequent oxygenation. Increased LV dimensions The significant increase in LVEDD and LVEDD z-score post-repair strongly supports the concept of mechanical compression contributing to LV hypoplasia in CDH [3, 4, 16]. Reducing the herniated viscera alleviates this compression, allowing the LV to assume a more normal geometry and fill more readily. This finding aligns with previous studies showing improved LV dimensions weeks to months post-repair [17, 18], but our data demonstrated this change occurred rapidly within days and continued throughout follow-up. The increase in LV dimensions post-repair is likely multifactorial. Primarily, it reflects relief of direct mechanical compression by the herniated viscera. Secondarily, the rapid improvement in RV function and reduction in ESPAP post-repair (Table 2) likely augments effective pulmonary blood flow. This increased transpulmonary flow enhances left atrial filling and LV preload, further contributing to the observed increase in LVEDD.The correlation between greater post-repair improvement/increase in LV size and lower FiO2 at 7 days suggests improved LV preload and output may contribute to better pulmonary perfusion and gas exchange over time. Transient LV systolic dysfunction The observed transient decrease in LVFS and LVEF E-Post-Op is a critical finding. Potential mechanisms could include: (1) Altered loading conditions due to sudden decompression and an increase in LV preload against potentially elevated afterload (systemic vascular resistance changes). (2) Myocardial stunning/ischemia due to the surgical stress, potential intraoperative hemodynamic fluctuations, and the inflammatory response. (3) Subclinical ischemia due to the perioperative events that might cause subtle ischemia, particularly in a ventricle potentially compromised by pre-existing hypoplasia and strain. (4) Septal interaction as the rapid reduction in RV afterload and improvement in RV function may alter ventricular interdependence, transiently affecting LV mechanics. The significant correlation between the magnitude of LVEF decrease and higher E-Post-Op VIS underscores the clinical relevance of this dysfunction, necessitating increased hemodynamic support. This finding highlights the importance of anticipating potential LV compromise in the immediate post-operative period, even as RV strain improves. Our results are consistent with studies reporting LV dysfunction post-CDH repair [19, 20], but provide clearer temporal association and correlation with support needs. While the observed decrease in LVEF (58% to 52%) and LVGLS (-17.2% to -15.4%) reached statistical significance, it is important to acknowledge that the absolute values largely remained within or near the lower limits of published normative neonatal ranges. Specifically, a mean LVEF of 52% in the context of a post-surgical neonate with CDH may represent a mild functional perturbation rather than overt clinical heart failure. However, the significant correlation between the degree of decline in LVEF and the peak post-operative VIS suggests that even this modest decrement in contractility has hemodynamic consequences that necessitate increased pharmacologic support. Furthermore, the ‘normal’ GLS for a CDH neonate is not well established; some data suggest these patients exhibit subclinical dysfunction even when EF is preserved. Therefore, the change from baseline is likely the most relevant metric, indicating a stress response to the surgical intervention that warrants clinical vigilance. Altered LV diastolic function The transient decrease in E/A ratio suggests a shift towards impaired relaxation in the E-Post-Op period. This could result from myocardial edema, ischemia, or changes in ventricular compliance due to altered geometry post-decompression. The lack of change in E/e’ ratio suggests that the mean left atrial pressure might not be significantly elevated acutely, implying the altered E/A may primarily reflect intrinsic myocardial changes rather than overtly elevated filling pressures at this specific time point. Further studies with serial diastolic assessment are needed. Improved RV function and PH The significant improvements in TAPSE, RVGLS, and ESPAP confirm the beneficial impact of surgical repair on RV afterload and function [8, 9]. Reducing lung compression and mediastinal shift likely improves pulmonary vascular mechanics and facilitates a decrease in PAP. The reduction in ventricular septal flattening directly reflects this decrease in RV pressure overload. We acknowledge that the observed increase in TAPSE, while statistically significant, represents a change from a normal value (16.2 mm) to a higher-normal value (18.8 mm). This may be partly influenced by geometric changes in RV positioning following reduction of the hernia and mediastinal shift. However, the concurrent improvement in RVGLS, a less angle-dependent measure of myocardial deformation, corroborates the finding of improved RV systolic mechanics post-repair, likely due to reduced afterload from falling pulmonary artery pressures. Clinical implications These findings have direct implications for management: Anticipate LV support: Clinicians should be vigilant for signs of LV dysfunction (e.g., hypotension, poor perfusion, rising lactate) in the first 48–72 h post-repair, even as respiratory status and PH may be improving. Inotropes with lusitropic properties (e.g., Milrinone) may be particularly beneficial in supporting both systolic function and the observed altered diastolic relaxation pattern.Interpret LV size in context: A “normalizing” LVEDD post-repair is a positive sign, reflecting reduced compression. However, systolic function needs simultaneous assessment.Monitor diastolic function: Altered relaxation may contribute to hemodynamic instability and warrant tailored fluid management and heart rate optimization.Guiding Weaning: Improvements in RV function and PAP are positive, but concurrent LV status must be considered when weaning cardiorespiratory support. Anticipate LV support: Clinicians should be vigilant for signs of LV dysfunction (e.g., hypotension, poor perfusion, rising lactate) in the first 48–72 h post-repair, even as respiratory status and PH may be improving. Inotropes with lusitropic properties (e.g., Milrinone) may be particularly beneficial in supporting both systolic function and the observed altered diastolic relaxation pattern. Anticipate LV support: Clinicians should be vigilant for signs of LV dysfunction (e.g., hypotension, poor perfusion, rising lactate) in the first 48–72 h post-repair, even as respiratory status and PH may be improving. Inotropes with lusitropic properties (e.g., Milrinone) may be particularly beneficial in supporting both systolic function and the observed altered diastolic relaxation pattern. Interpret LV size in context: A “normalizing” LVEDD post-repair is a positive sign, reflecting reduced compression. However, systolic function needs simultaneous assessment. Interpret LV size in context: A “normalizing” LVEDD post-repair is a positive sign, reflecting reduced compression. However, systolic function needs simultaneous assessment. Monitor diastolic function: Altered relaxation may contribute to hemodynamic instability and warrant tailored fluid management and heart rate optimization. Monitor diastolic function: Altered relaxation may contribute to hemodynamic instability and warrant tailored fluid management and heart rate optimization. Guiding Weaning: Improvements in RV function and PAP are positive, but concurrent LV status must be considered when weaning cardiorespiratory support. Guiding Weaning: Improvements in RV function and PAP are positive, but concurrent LV status must be considered when weaning cardiorespiratory support. Limitations The sample size, while reasonable for a single-center CDH study, limits subgroup analyses (e.g., patch vs. primary repair impact). The cohort had no mortality before discharge, limiting analysis of predictors of fatal outcomes. Generalizability may be affected by single-center management protocols. Short follow-up duration and Selection bias toward stable surgical candidates also were from the limitation of this study. Post-hoc testing was not performed. Prenatal LHR/O/E LHR data were not consistently available. Information on shunt directions at the atrial or ductal level, these data were not systematically collected. Conclusions This study demonstrates that surgical repair of CDH induces significant acute changes in cardiac performance. While reduction of herniated viscera rapidly improves LV dimensions (indicating relief of compression) and RV function/PAP, it is also associated with a transient impairment in LV systolic function and altered diastolic relaxation pattern in the immediate post-operative period. Recognizing the potential for transient LV compromise allows for anticipatory hemodynamic support, optimizing outcomes for these critically ill infants. Future research should focus on identifying predictors of significant Post-Op LV dysfunction and evaluating targeted therapeutic strategies.